Virtual men’s health options have “improved access for patients who otherwise cannot reach doctors or who are otherwise embarrassed to go see someone in person,” says Ranjith Ramasamy, MD.
In this video, Ranjith Ramasamy, MD, discusses the emergence of online men’s health companies for treating erectile dysfunction and other conditions. Ramasamy is an associate professor of urology and director of male reproductive medicine and surgery at the University of Miami Miller School of Medicine.
Study highlights how DTC online platforms often fail to convey risks of testosterone therapy
December 8th 2022“While there’s benefit in improving access, there’s also potential for harm when providers fail to follow evidence-based guidelines, or when the benefits and risks of treatment are not appropriately communicated," said Joshua A. Halpern, MD.
Expert explains latest findings with oral softgel capsule for testosterone replacement therapy
November 11th 2021"We didn't see any clinically significant changes on the prostate gland, which is very important for the urologists who see people who have prostate cancer or prostate enlargement," says Ronald Swerdloff, MD.
Study supports use of androgen receptor inhibitors in older men with nmCRPC
July 26th 2021Researchers from the FDA’s Center for Drug Evaluation and Research determined that the benefits of androgen receptor inhibitors outweighed the risks in men aged ≥80 years with nonmetastatic castration-resistant prostate cancer.
2 Clarke Drive
Cranbury, NJ 08512